Roche / Genentech (Internal Manufacturing & CustomBiotech)

Basel, Switzerland

Biologics mAb Cell Therapy Gene Therapy (AAV) Oligonucleotide mRNA Small Molecule

Program data pending ClinicalTrials.gov matching

60.0

Signal Score

○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (10) ○ EMA GMP ○ MHRA GMP

Quick Facts: Roche / Genentech (Internal Manufacturing & CustomBiotech)

Signal Score: 60.0/100
Quality Compliance: Assessment pending
Headquarters: Basel, Switzerland
Modalities: Biologics, mAb, Cell Therapy, Gene Therapy (AAV), Oligonucleotide, mRNA, Small Molecule
Active Programs: No ClinicalTrials.gov matches confirmed
Data Sources: FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By: CDMO Signal — independent CDMO intelligence platform

About Roche / Genentech (Internal Manufacturing & CustomBiotech)

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —

No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.

FDA InspectionsNo US records on file

No FDA inspection records found for this manufacturer

Quality score requires FDA inspection data

Operations —

No ClinicalTrials.gov facility matches confirmed for this manufacturer.

Programs — no verified data

Sponsors— no verified data

ModalitiesBiologics, mAb, Cell Therapy, Gene Therapy (AAV), Oligonucleotide, mRNA, Small Molecule

No clinical trial matches found for this manufacturer

Operational score requires ClinicalTrials.gov data

Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.

Financial Stability

Profile-based financial assessment

SEC FilingsPrivate company

Private company

Financial assessment: 60.0/100

Capacity

Profile-based capacity assessment

Recent Press10 articles

Broad modality coverage (7 modalities)

Recent News 10 articles

news Wed, 23 Ju

Genentech eliminates 87 jobs in another round of South San Francisco layoffs - Fierce Biotech

Source →

news Wed, 21 Ja

Roche Raises NC Manufacturing Investment to $2B To Support Obesity Challenge - BioSpace

Source →

news Wed, 18 Ma

Swiss Roche builds its own AI factory with NVIDIA – with Genentech in California - European Biotechnology Magazine

Source →

news Wed, 06 Ma

Recursion Reports First Quarter Financial Results and Provides Business Update - The Manila Times

Source →

news Tue, 20 Ja

Genentech dials up more Holly Springs growth - Business North Carolina

Source →

news Tue, 20 Ja

Swiss drugmaker surges Wake County investment to $2 billion, 500 jobs - The Business Journals

Source →

news Thu, 23 Oc

Lonza's recently purchased Calif. biologics site plays key role in sales rebound - Fierce Pharma

Source →

news Mon, 16 Ma

Roche Launches New ‘AI Factory’ To Speed Drug Development - Forbes

Source →

news Mon, 02 Fe

Genentech Expands RNAi Pipeline Through Global Licensing Deal - BioPharm International

Source →

news Fri, 09 Ja

AI Fuels Genentech’s R&D Ecosystem - Genentech

Source →

Frequently Asked Questions About Roche / Genentech (Internal Manufacturing & CustomBiotech)

What is Roche / Genentech (Internal Manufacturing & CustomBiotech)'s CDMO Signal Score?

Roche / Genentech (Internal Manufacturing & CustomBiotech) has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.

Evaluating Roche / Genentech (Internal Manufacturing & CustomBiotech) for a manufacturing program?

Use the free AI matchmaker to compare Roche / Genentech (Internal Manufacturing & CustomBiotech) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.

Find & compare CDMOs →

Represent this organization? Contact us to verify or update this profile.

See all CDMOs in:

Biologics CDMOs → Cell Therapy CDMOs → Gene Therapy (AAV) CDMOs → Oligonucleotide CDMOs → mRNA CDMOs →